Transcriptional regulation of type B human natriuretic peptide receptor gene promoter: Dependence on Sp1

Hypertension

Volumn 44, Issue 3, 2004, Pages 283-288

  Rahmutula, Dolkun ^a   Cui, Junfeng ^a   Chen, Songcang ^a   Gardner, David G ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Muscle, smooth, vascular; Natriuretic peptide receptor; Transcription

Indexed keywords

BETA GALACTOSIDASE; BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE RECEPTOR; COMPLEMENTARY DNA; GENOMIC DNA; HORMONE RECEPTOR; LUCIFERASE; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; UNCLASSIFIED DRUG;

ANIMAL CELL; AORTA; ARTICLE; BINDING SITE; DNA SEQUENCE; ENZYME ASSAY; EXPRESSION VECTOR; FIBROBLAST CULTURE; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GENOME; HYPERTENSION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION; VASCULAR SMOOTH MUSCLE;

5' UNTRANSLATED REGIONS; ANIMALS; AORTA; BASE SEQUENCE; BINDING SITES; CELLS, CULTURED; DNA, COMPLEMENTARY; DROSOPHILA MELANOGASTER; FIBROBLASTS; GENES, REPORTER; GUANYLATE CYCLASE; LUCIFERASES; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; MUTAGENESIS, SITE-DIRECTED; MYOCYTES, SMOOTH MUSCLE; PROMOTER REGIONS (GENETICS); RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ATRIAL NATRIURETIC FACTOR; REGULATORY SEQUENCES, NUCLEIC ACID; SEQUENCE DELETION; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 4444305268     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000136908.60317.92     Document Type: Article

References (34)

1. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med. 1998;339:321-328.
2. Koller KJ, Goeddel DV. Molecular biology of the natriuretic peptides and their receptors. Circulation. 1992;86:1081-1088.
3. Potter LR, Hunter T. Guanylyl cyclase-linked natriuretic peptide receptors: structure and regulation. J Biol Chem. 2001;276:6057-6060.
4. Pham I, Sediame S, Maistre G, Roudot-Thoraval F, Chabrier PE, Carayon A, Adnot S. Renal and vascular effects of C-type and atrial natriuretic peptides in humans. Am J Physiol. 1997;273:R1457-R1464.
5. Chusho H, Tamura N, Ogawa Y, Yasoda A, Suda M, Miyazawa T, Nakamura K, Nakao K, Kurihara T, Komatsu Y, Itoh H, Tanaka K, Saito Y, Katsuki M. Dwarfism and early death in mice lacking C-type natriuretic peptide. Proc Natl Acad Sci U S A. 2001;98:4016-4021.
6. Deschepper CF, Picard S. Effects of C-type natriuretic peptide on rat astrocytes: regional differences and characterization of receptors. J Neurochem. 1994;62:1974-1982.
7. Brown J, Chen Q, Hong G. An autocrine system for C-type natriuretic peptide within rat carotid neointima during arterial repair. Am J Physiol. 1997;272:H2919-H2931.
8. Furuya M, Aisaka K, Miyazaki T, Honbou N, Kawashima K, Ohno T, Tanaka S, Minamino N, Kangawa K, Matsuo H. C-type natriuretic peptide inhibits intimal thickening after vascular injury. Biochem Biophys Res Commun. 1993;193:248-253.
9. Ueno H, Haruno A, Morisaki N, Furuya M, Kangawa K, Takeshita A, Saito Y. Local expression of C-type natriuretic peptide markedly suppresses neointimal formation in rat injured arteries through an autocrine/paracrine loop. Circulation. 1997;96:2272-2279.
10. Cao L, Wu J, Gardner DG. Atrial natriuretic peptide suppresses the transcription of its guanylyl cyclase-linked receptor. J Biol Chem. 1995; 270:24891-24897.
11. Cao L, Chen SC, Cheng T, Humphreys MH, Gardner DG. Ligand-dependent regulation of NPR-A gene expression in inner medullary collecting duct cells. Am J Physiol. 1998;275:F119-F125.
12. Liang F, Schaufele F, Gardner DG. Sp1 dependence of natriuretic peptide receptor A gene transcription in rat aortic smooth muscle cells. Endocrinology. 1999;140:1695-1701.
13. Liang F, Schaufele F, Gardner DG. Functional interaction of NF-Y and Sp1 is required for type A natriuretic peptide receptor gene transcription. J Biol Chem. 2001;276:1516-1522.
14. Garg R, Pandey KN. Angiotensin II-mediated negative regulation of Npr1 promoter activity and gene transcription. Hypertension. 2003;41: 730-736.
15. Yanaka N, Kotera J, Omori K. Isolation and characterization of the 5′-flanking regulatory region of the human natriuretic peptide receptor C gene. Endocrinology. 1998;139:1389-1400.
16. Cao L, Gardner DG. Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts. Hypertension. 1995;25:227-234.
17. Chang MS, Lowe DG, Lewis M, Hellmiss R, Chen E, Goeddel DV. Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases. Nature. 1989:341:68-72.
18. Chang AT, Polansky JR, Crook RB. Natriuretic peptide receptors on human trabecular meshwork cells. Curr Eye Res. 1996;15:137-143.
19. Silverman ES, Collins T. Pathways of Egr-1-mediated gene transcription in vascular biology. Am J Pathol. 1999;154:665-670.
20. Rehemudula D, Nakayama T, Soma M, Takahashi Y, Uwabo J, Sato M, Izumi Y, Kanmatsuse K, Ozawa Y. Structure of the type B human natriuretic peptide receptor gene and association of a novel microsatellite polymorphism with essential hypertension. Circ Res. 1999:84:605-610.
21. Flesch M. On the trail of cardiac specific transcription factors. Cardiovasc Res. 2001;50:3-6.
22. Sugawara A, Uruno A, Kudo M, Ikeda Y, Sato K, Taniyama Y, Ito S, Takeuchi K. Transcription suppression of thromboxane receptor gene by peroxisome proliferator-activated receptor-gamma via an interaction with Sp1 in vascular smooth muscle cells. J Biol Chem. 2002;277:9676-9683.
23. Kavurma MM, Khachigian LM. Sp1 inhibits proliferation and induces apoptosis in vascular smooth muscle cells by repressing p21WAF1/Cip1 transcription and cyclin D1-Cdk4-p21WAF1/Cip1 complex formation. J Biol Chem. 2003;278:32537-32543.
24. Herman JP, Dolgas CM. Rucker D, Langub MC, Jr. Localization of natriuretic peptide-activated guanylate cyclase mRNAs in the rat brain. J Comp Neurol. 1996;369:165-187.
25. Yasoda A, Ogawa Y, Suda M, Tamura N, Mori K, Sakuma Y, Chusho H, Shiota K, Tanaka K, Nakao K. Natriuretic peptide regulation of endochondral ossification. Evidence for possible roles of the C-type natriuretic peptide/guanylyl cyclase-B pathway. J Biol Chem. 1998;273:11695-11700.
26. Noubani A, Farookhi R, Gutkowska J. B-type natriuretic peptide receptor expression and activity are hormonally regulated in rat ovarian cells. Endocrinology. 2000;141:551-559.
27. Yasoda A, Komatsu Y, Chusho H, Miyazawa T, Ozasa A, Miura M, Kurihara T, Rogi T, Tanaka S, Suda M, Tamura N, Ogawa Y, Nakao K. Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Nat Med. 2004;10:80-86.
28. Suga S, Nakao K, Kishimoto I, Hosoda K. Mukoyama M, Arai H, Shirakami G, Ogawa Y, Komatsu Y, Nakagawa O, Hama N, Imura H. Phenotype-related alteration in expression of natriuretic peptide receptors in aortic smooth muscle cells. Circ Res. 1992;71:34-39.
29. Suga S, Nakao K, Itoh H, Komatsu Y, Ogawa Y, Hama N, Imura H. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system". J Clin Invest. 1992;90:1145-1149.
30. Suga S, Itoh H, Komatsu Y, Ogawa Y, Hama N, Yoshimasa T, Nakao K. Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells-evidence for CNP as a novel autocrine/paracrine regulator from endothelial cells. Endocrinology. 1993;133: 3038-3041.
31. Igaki T, Itoh H, Suga S, Komatsu Y, Ogawa Y, Doi K, Yoshimasa T, Nakao K. Insulin suppresses endothelial secretion of C-type natriuretic peptide, a novel endothelium-derived relaxing peptide. Diabetes. 1996; 45:S62-S64.
32. Doi K, Itoh H, Komatsu Y, Igaki T, Chun TH, Takaya K, Yamashita J, Inoue M, Yoshimasa T, Nakao K. Vascular endothelial growth factor suppresses C-type natriuretic peptide secretion. Hypertension. 1996;27: 811-815.
33. Porter JG, Catalano R, McEnroe G, Lewicki JA. Protter AA. C-type natriuretic peptide inhibits growth factor-dependent DNA synthesis in smooth muscle cells. Am J Physiol. 1992;263:C1001-C1006.
34. Furuya M, Yoshida M, Hayashi Y, Ohnuma N, Minamino N. Kangawa K, Matsuo H. C-type natriuretic peptide is a growth inhibitor of rat vascular smooth muscle cells. Biochem Biophys Res Commun. 1991;177:927-931.